Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Generation Bio Co. (GBIO)

Generation Bio Co. (GBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Generation Bio Co. 301 BINNEY STREET CAMBRIDGE MA 02142 USA

www.generationbio.com Employees: 174 P: 617-655-7500

Description:

Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo produced by a scalable capsid-free manufacturing process which uses proprietary cell-free rapid enzymatic synthesis. Generation Bio Co. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 90,171
Enterprise Value, $K 23,721
Shares Outstanding, K 66,793
Annual Sales, $ 5,900 K
Annual Net Income, $ -126,610 K
Last Quarter Sales, $ 7,550 K
Last Quarter Net Income, $ -15,310 K
EBIT, $ -157,240 K
EBITDA, $ -151,980 K
60-Month Beta 2.82
% of Insider Shareholders 21.10%
% of Institutional Shareholders 95.22%
Float, K 52,700
% Float 78.90%
Short Volume Ratio 0.28

Growth:

1-Year Return 14.78%
3-Year Return -92.42%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/06/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -2.19
EPS Growth vs. Prev Qtr 25.81%
EPS Growth vs. Prev Year 46.51%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -104.85%
Return-on-Assets % -49.54%
Profit Margin % -2,145.93%
Debt/Equity 0.00
Price/Sales 15.73
Price/Cash Flow N/A
Price/Book 0.89
Book Value/Share 1.56
Interest Coverage -11.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar